Eficacia del mantenimiento con azatioprina sin ciclosporina oral tras un brote grave de colitis ulcerosa refractario a esteroides intravenosos

Huguet Malavés, José María; Ruiz Sánchez, Lucía; Durá Ayet, Ana Belén; Rodríguez García, Isabel; Latorre Sánchez, Mercedes; Ferrer Arranz, Luis; Tuset Ruiz, Juan Antonio; Tomé Toyosato, Alica; Medina Chuliá, Enrique.
Gastroenterol. hepatol. (Ed. impr.) ; 31(5): 280-284, mayo 2008. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-84643

Documentos relacionados

  1. A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease.
  2. Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.
  3. A phase I, single-sequence, open-label study to evaluate the drug-drug interaction between hetrombopag and cyclosporine in healthy Chinese subjects.
  4. Systematic Review and Meta-Analysis of Thiopurine Metabolite Levels and Biochemical Remission in Autoimmune Hepatitis.
  5. Population pharmacokinetics and dose simulation of cyclosporine in Chinese children with nephrotic syndrome: Effects of weight and total cholesterol.
  6. Pharmacological surrogates of allograft outcome.
  7. Cyclic peptide oral bioavailability: Lessons from the past.
  8. Time-Dissociated Pharmacokinetic Pharmacodynamic Model of Cyclosporine Among Malaysian Renal Transplant Recipients.
  9. The Effect of Particle Size on the Absorption of Cyclosporin A Nanosuspensions.
  10. Pharmacokinetic control of orally dosed cyclosporine A with mucosal drug delivery system.